DLC1 anticorps (N-Term)
-
- Antigène Voir toutes DLC1 Anticorps
- DLC1 (Deleted in Liver Cancer 1 (DLC1))
-
Épitope
- N-Term
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp DLC1 est non-conjugé
-
Application
- Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
- Specificité
- DLC-1 Polyclonal Antibody detects endogenous levels of DLC-1 protein.
- Attributs du produit
- Rabbit Polyclonal to DLC-1.
- Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogène
- Synthesized peptide derived from the N-terminal region of human DLC-1.
- Isotype
- IgG
- Top Product
- Discover our top product DLC1 Anticorps primaire
-
-
- Indications d'application
- IHC 1:100-1:300, IF 1:200-1:1000, ELISA 1:10000,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C.
-
- Antigène
- DLC1 (Deleted in Liver Cancer 1 (DLC1))
- Autre désignation
- DLC-1 (DLC1 Produits)
- Synonymes
- anticorps ARHGAP7, anticorps HP, anticorps STARD12, anticorps p122-RhoGAP, anticorps rhogap7, anticorps DLC-1, anticorps StARD12, anticorps Dlc-1, anticorps A730069N07Rik, anticorps Arhgap7, anticorps dlc-1, anticorps RhoGAP, anticorps Dlc1, anticorps DLC1 Rho GTPase activating protein, anticorps DLC1 Rho GTPase activating protein S homeolog, anticorps rho GTPase-activating protein 7, anticorps deleted in liver cancer 1, anticorps DLC1, anticorps dlc1.S, anticorps dlc1, anticorps LOC100456847, anticorps Dlc1, anticorps LOC100729904
- Poids moléculaire
- 122.827 kDa
- ID gène
- 10395
- UniProt
- Q96QB1
- Pathways
- Tube Formation, Positive Regulation of Endopeptidase Activity
-